Skip to Content Skip to Navigation

Over ons Praktische zaken Waar vindt u ons dr. R.S.N. (Rudolf) Fehrmann

University Medical Center Groningen

dr. R.S.N. (Rudolf) Fehrmann

MD/PhD

Profielfoto van dr. R.S.N. (Rudolf) Fehrmann

Faculteit Medische Wetenschappen/UMCG

Telefoon:

E-mail:

r.s.n.fehrmann umcg.nl

Homepage ORCID Research Portal

Research interests

My practical and theoretical background enables me to take an integrative omics approach to identify driver genetic alterations, genes and biological pathways that are relevant for the pathophysiological behaviour and treatment response of tumors and rapidly translate these findings to clinical practice.

In addition to my training as a medical doctor, I completed one full year of Mathematics and Computer Science, after which I continued to obtain my MSc degree in Cognitive Science and Engineering.

In parallel to my medical studies, I worked for several years as a bio-informatician at the Department of Genetics, UMCG. In 2010, I obtained my PhD on high dimensional data analysis for new insights into ovarian cancer phenotypes, after which I continued as an affiliated post-doc at the Departments of Genetics and Medical Oncology (UMCG).

I followed the residency program in Internal Medicine / Medical Oncology and now work as a medical oncologist (staff member) at the department of Medical Oncology at the UMCG. In addition, I am a principal investigator at the Cancer Research Center Groningen in the research programmes: ‘Guided Treatment in Optimal Selected Cancer Patients (GUTS)’ and ‘Damage and Repair in Cancer Development and Cancer (DARE)’.

Publicaties

Identification of new head and neck squamous cell carcinoma molecular imaging targets

van Schaik, J. E., van der Vegt, B., Slagter-Menkema, L., van der Laan, B. F. A. M., Witjes, M. J. H., Oosting, S. F., Fehrmann, R. S. N. & Plaat, B. E. C., apr.-2024, In: Oral Oncology. 151, 7 blz., 106736.

Onderzoeksoutput › › peer review

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Björk, J. R., Bolte, L. A., Maltez Thomas, A., Lee, K. A., Rossi, N., Wind, T. T., Smit, L. M., Armanini, F., Asnicar, F., Blanco-Miguez, A., Board, R., Calbet-Llopart, N., Derosa, L., Dhomen, N., Brooks, K., Harland, M., Harries, M., Lorigan, P., Manghi, P., Marais, R., & 20 anderenNewton-Bishop, J., Nezi, L., Pinto, F., Potrony, M., Puig, S., Serra-Bellver, P., Shaw, H. M., Tamburini, S., Valpione, S., Waldron, L., Zitvogel, L., Zolfo, M., de Vries, E. G. E., Nathan, P., Fehrmann, R. S. N., Spector, T. D., Bataille, V., Segata, N., Hospers, G. A. P. & Weersma, R. K., mrt.-2024, In: Nature Medicine. 30, blz. 785–796 12 blz.

Onderzoeksoutput › › peer review

Andere ontwikkelingen in het kankeronderzoek: Toepassing kunstmatige intelligentie in de oncologie

Fehrmann, R., 2-feb.-2023, Kanker: Over de laatste ontwikkelingen in het kankeronderzoek. Bio Wetenschap + Maatschappij, blz. 131-134 4 blz.

Onderzoeksoutput ›

Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

Bolte, L. A., Lee, K. A., Björk, J. R., Leeming, E. R., Campmans-Kuijpers, M. J. E., de Haan, J. J., Vila, A. V., Maltez-Thomas, A., Segata, N., Board, R., Harries, M., Lorigan, P., de Vries, E. G. E., Nathan, P., Fehrmann, R., Bataille, V., Spector, T. D., Hospers, G. A. P. & Weersma, R. K., mei-2023, In: JAMA oncology. 9, 5, blz. 705-709 5 blz.

Onderzoeksoutput › › peer review

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

van Not, O. J., Wind, T. T., Ismail, R. K., Bhattacharya, A., Jalving, M., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Haanen, J. B., Kapiteijn, E., Bloem, M., Piersma, D., van Rijn, R. S., Stevense-den Boer, M., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., & 4 anderenBlokx, W. A. M., Suijkerbuijk, K. P. M., Fehrmann, R. S. N. & Hospers, G. A. P., 26-mei-2023, In: Cancers. 15, 11, 12 blz., 2922.

Onderzoeksoutput › › peer review

Current state and prospects of artificial intelligence in allergy

van Breugel, M., Fehrmann, R. S. N., Bügel, M., Rezwan, F. I., Holloway, J. W., Nawijn, M. C., Fontanella, S., Custovic, A. & Koppelman, G. H., okt.-2023, In: Allergy. 78, 10, blz. 2623-2643 21 blz.

Onderzoeksoutput › peer review

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., Bhattacharya, A., van Binnendijk, R. S., GeurtsvanKessel, C. H., Dingemans, A-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., & 3 anderenvan Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., aug.-2023, In: ESMO Open. 8, 4, 3 blz., 101599.

Onderzoeksoutput › › peer review

FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics

Stok, C., Tsaridou, S., van den Tempel, N., Everts, M., Wierenga, E., Bakker, F. J., Kok, Y., Alves, I. T., Jae, L. T., Raas, M. W. D., Huis In 't Veld, P. J., de Boer, H. R., Bhattacharya, A., Karanika, E., Warner, H., Chen, M., van de Kooij, B., Dessapt, J., ter Morsche, L., Perepelkina, P., & 6 anderenFradet-Turcotte, A., Guryev, V., Tromer, E. C., Chan, K-L., Fehrmann, R. S. N. & van Vugt, M. A. T. M., 25-jul.-2023, In: Cell reports. 42, 7, 27 blz., 112668.

Onderzoeksoutput › › peer review

MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer

Metman, M. J. H., Jonker, P. K. C., Sondorp, L. H. J., van Hemel, B. M., Sywak, M. S., Gill, A. J., Jansen, L., van Diest, P. J., van Ginhoven, T. M., Löwik, C. W. G. M., Nguyen, A. H., Robinson, D. J., van Dam, G. M., Links, T. P., Coppes, R. P., Fehrmann, R. S. N. & Kruijff, S., 29-nov.-2023, (E-pub ahead of print) In: European Journal of Nuclear Medicine and Molecular Imaging. 11 blz.

Onderzoeksoutput › › peer review

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

van der Veldt, A. A. M., Oosting, S. F., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A. M. C., Smit, E. F., Hiltermann, T. J. N., Hartog, G. D., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., & 3 anderenvan Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., feb.-2023, In: ESMO Open. 8, 1, 2 blz., 100785.

Onderzoeksoutput: Letter › › peer review

Alle (144) publicaties

Pers/media

KWF-subsidie voor onderzoek naar werking immuuntherapie bij triple-negatieve borstkanker

Rudolf Fehrmann

22/07/2022 → 25/07/2022

Pers / media: Expert Comment ›

UMCG krijgt miljoen euro voor onderzoek naar therapie bij agressieve borstkanker

Marcel van Vugt & Rudolf Fehrmann

22/07/2022

Pers / media: Expert Comment ›

UMCG krijgt miljoen euro voor onderzoek naar therapie bij agressieve borstkanker

Rudolf Fehrmann

22/07/2022

Pers / media: Expert Comment ›

Prangende vragen én antwoorden over artificial intelligence in de zorg

Rudolf Fehrmann

02/09/2021

Pers / media: Expert Comment ›

Artificial Intelligence in Medical Oncology

Rudolf Fehrmann

02/09/2021

Pers / media: Expert Comment ›

Interview on Artificial Intelligence in Medical Oncology

Rudolf Fehrmann

28/08/2020

Pers / media: Expert Comment ›

Vlog: YAG Interdisciplinary Project

Marthe Walvoort & Rudolf Fehrmann

05/12/2018

Pers / media: Expert Comment ›

Looking back: ECR Lunch on work / life balance

Rudolf Fehrmann

27/08/2018

Pers / media: Overig ›

UMCG krijgt subsidie voor onderzoek naar kanker

Rudolf Fehrmann

21/07/2017

Pers / media: Expert Comment ›

Press releases: Gene expression analysis identifies global gene dosage sensitivity in cancer

Rudolf Fehrmann

11/01/2014 → 20/01/2015

Pers / media: Onderzoek ›

Alle (10) pers/media

Bekijk volledig onderzoeksprofiel

Volg de RUGfacebook twitter linkedin rss instagram youtube